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Objectives. p120ctn is a component of the catenin family. To date, there have only been two studies examining expression
levels of p120ctn in oral squamous cell carcinoma (OSCC).
Materials and methods. Paraffined specimens of 113 OSCCs and 12 of normal mucosa were examined by
immunohistochemistry. Frozen samples of 20 OSCCs and 5 of normal mucosa were examined by Western blot (WB). Results
were correlated with clinicopathological parameters. Five cell lines were examined by immunofluorescence,
immunocytochemistry, and WB to show immunoreactivity and cellular localization of p120ctn.
Results. Altered p120ctn expression was observed in 109/113 cases of OSCC. Heterogenous cytoplasmic/nuclear expression
was associated with loss of membranous distribution (88/113 cases). Complete loss of expression was noted in 21/113 cases.
Increased cytoplasmic expression was evident in all positive cases, without significant correlation among p120ctn staining/
pattern and grading/stage. Reduction/absence of p120ctn expression was related to poor prognosis (P < .05).
Conclusion. p120ctn delocalization/loss of expression could be an independent prognostic marker in OSCC. (Oral Surg Oral
Med Oral Pathol Oral Radiol 2013;115:789-798)The incidence of lymph node metastases is signiﬁcantly
correlated with the clinical stage and the localization of
primary tumors, as well as with the differentiation of
tumor cells and their adherence capability.1,2 Intercel-
lular adhesiveness depends on the glycoprotein family
of cadherins.3 These proteins present an extra-cellular
domain that binds to adjacent cells, a transmembrane
domain, and an intracellular domain which binds cat-
enin proteins.4 E-cadherin, a 120-kd transmenbrane
glycoprotein, mediates epithelial adhesiveness function
in the zonula adherens junctions.
Recently, a novel member of the catenin family,
homologous to b- and g-catenin, called p120ctn
protein, has been described.5 The human p120ctn geneThis work was supported by a grant of the Ministero della Università
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Open access under CC BY-NC-ND license.(CTNND) is localized on the long arm of chromosome
11, in band 11q11.6 p120ctn, b- and g-catenin bind
different regions of E-cadherin. In fact, p120ctn binds
at the juxtamembrane region of the cytoplasmic
domain, whereas b- and g-catenin bind more distally.7,8
For this reason, p120ctn coexists in E-cadherin
complexes with either b- or g-catenin.7 It is thought
that p120ctn may modulate adhesiveness of cadherins,
but its exact role is unknown.9 The possible role of the
cadherin/catenin complex in human carcinogenesis has
been suggested by several studies.10,11 It is thought that
down-regulation of E-cadherin is directly related to
invasiveness and progression of many human epithelial
tumor types,11 including oral squamous cell carcinomas
(OSCC).12
Moreover, it was also suggested that, given the
role exerted by catenins for proper functioning of
E-cadherin, loss of expression or mutations of these
proteins might be functionally equivalent to E-cadherin
loss of function.Statement of Clinical Relevance
To the best of our knowledge, no studies have found
a statistically signiﬁcant correlation between
p120ctn expression in OSCCs and patient survival,
whereas the result of the present study clearly dis-
played that p120ctn delocalization/loss of expression
seems to be a useful independent prognostic marker
in oral squamous cell carcinoma.
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been extensively studied in many forms of human
cancers, including OSCC,13-16 less is known about the
expression levels of p120ctn in human cancers17-20 to
date there have been no studies on its expression in
OSCCs, except for our previous study involving on cell
lines21 and a very recent one that looked at potentially
malignant oral lesions.22
Therefore, in the present study, we used immuno-
histochemistry to retrospectively evaluate p120ctn
expression in 113 parafﬁned specimens of OSCC and
12 parafﬁned specimens of human oral normal epithe-
lium. Moreover, 5 OSCC cell lines, 20 frozen speci-
mens of human OSCCs, and 5 frozen specimens
of human oral normal epithelium were investigated
by immunocytochemistry, immunoﬂuorescence, and
western blotting (WB) techniques to evaluate p120ctn
expression.
MATERIALS AND METHODS
Cell lines
Five cell lines were used: NCTC2544 (normal immor-
talized keratinocytes), OSC20 (well differentiated SCC
cell line), CAL33 and CAL27 (moderately and poorly
differentiated OSCC cell lines respectively), and KM5
(moderately differentiated gingival squamous cell
carcinoma [SCC]). The NCTC-2544 cell line originated
from skin keratinocytes of human origin (HL97002;
Interlab Cell Line Collection, Genova, Italy).23 KM5 cell
line originated from a human oral squamous cell carci-
noma of the tongue24 and was kindly sent by Prof.
Masaki Okafuji, Department of Pathology, Yamaguchi
University School of Medicine, Ube, Japan. CAL27 and
CAL33 cell lines originated from two human oral
squamous cell carcinomas of the tongue25,26 and were
kindly sent by Prof. J. L. Fischel, Center Antoine-
Lacassagne, Nice, France; CAL27 and CAL33 have
relatively long doubling times (35 and 43 h respectively).
OSC20 cell line originated from a human oral squamous
cell carcinoma27 and was kindly sent by Prof. N. Tanaka
and Dr. H. Kondo, Department of Oral Surgery, Sapporo
Medical University, School of Medicine, Sapporo,
Japan.
NCTC2544, CAL33, and CAL27, and KM5 cell
lines were cultured as monolayers in Dulbecco’s Modi-
ﬁed Eagle’s Medium (DMEM), supplemented with
10% fetal bovine serum (FBS), 2 mmol L-glutamine,
400 U/mL penicillin, 200 mg/mL streptomycin and kept
at 37C in humidiﬁed atmosphere with 5% CO2 in air.
OSC20 cell line was cultured as monolayers in Roswell
Park Memorial Institute (RPMI) 1640 medium, supple-
mented with 10% fetal bovine serum (FBS), 2 mmol
L-glutamine, 400 U/mL penicillin, 200 mg/mL strepto-
mycin and kept at 37C in humidiﬁed atmosphere with
5% CO2 in air.Oral specimens
113 primary OSCC samples, taken from surgical
resection specimens, were included in this study. None
of the patients had been treated previously. They
received surgical treatment with curative intention. No
case in this study involved patients with contempora-
neous multicentric lesions. Clinical data were reviewed
to record sex and age of the patient, and site and size of
the lesion. Cases in this study were included only when
a follow-up lasting at least 36 months was available.
Patients who died of postoperative complications within
30 days were excluded. The group consisted of 77 men
and 36 women with a mean age of 64 years (range
18-87). The histopathological grading was assessed on
parafﬁn-embedded hematoxylin-eosin (H.E.)-stained
sections, using the World Health Organization classiﬁ-
cation of histological differentiation (G1, G2, and G3),
and tumor extent was classiﬁed according to the Tumor
Node Metastasis (TNM) system by UICC (International
Union Against Cancer, 2000). Twenty of these cases
were also available as frozen specimens. Twelve par-
afﬁned and 5 frozen specimens of healthy oral mucosa
were obtained from patients who had undergone routine
oral surgical procedures with informed consent of the
donors. Fresh oral tissue was obtained at surgery. Tumor
material and normal mucosa were collected, snap frozen
in liquid nitrogen, and stored at 80C prior to use.Immunocytochemistry
Cells were cultured on glass slides precoated with poly-L-
lysine to enhance cell attachment. Cultured cells were
rinsedwith phosphate-buffered saline (PBS),ﬁxed in cold
acetone and air-dried. To improve the staining pattern, the
slides were boiled 3 times for 3 min in 10 mM citrate
buffer as antigen retrieval method. In order to prevent
non-speciﬁc binding, sections were then preincubated
with non-immune bovine serum (diluted 1:100 in PBS)
for 25min at room temperature (RT). Afterwashing twice
with TriseHCl buffer, primary antibodies were applied.
A negative control was performed in each run by
substituting primary antibodieswith non-immune reagent
(Dako Antibody Diluent, Dakopatts, Hamburg,
Germany). All the slides were washed twice in TriseHCl
buffer between each step. Primary antibody was diluted
using 0.05MTriseHCl buffer pH 7.2-7.6, containing 1%
bovine serum albumin and incubated at optimal dilution
and time: mouse monoclonal IgG antibody against
p120ctn (Transduction Laboratories, Lexington, KY,
USA), packaged at 0.25 mg/mL, was used at a dilution of
1:500. Sequential 20-min incubations with biotinylated
anti-mouse immunoglobulins and streptavidin conju-
gated to alkaline phosphatase were performed. Finally,
a new fast red substrate system (K0597; Dako, Glostrup,
Denmark) was applied as a chromogenic solution.
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estimated as a percentage of the ﬁnal number of 300
neoplastic cells of each case, and scored in four cate-
gories: membranous (>90% of the cell showed
a membranous positivity), cytoplasmic (>10% of the
cell showed a cytoplasmic positivity), nuclear (the cell
showed a nuclear positivity), and no staining.Immunofluorescence microscopy
Cells were grown on glass coverslips, ﬁxed with 4%
paraformaldehyde in PBS for 15 min at RT,
permeabilized with 0.5% Tryton-100 in PBS for 5 min,
washed in PBS and blocked for 30 min in PBS con-
taining 1% bovine serum albumin (BSA). Cells were
incubated with p120ctn monoclonal antibody (Trans-
duction Laboratories) at 1:500 dilution for 45 min at
37C in a moist chamber, washed in PBS and stained
with goat anti-mouse ﬂuorescein-conjugated IgG (Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA) at
1:200 dilution for 45 min at 37C in a moist chamber.
Finally, the coverslips were washed in PBS, mounted
onto glass slides with 90% glycerol in PBS and exam-
ined with a Leica DMLB ﬂuorescence microscope.28WB
An aliquot of frozen tissue (30-50 mg) and cellular
pellets were suspended in lysis buffer (PBS, con-
taining 1% Nonidet P40, 0.1% sodium dodecyl sul-
phate (SDS), 1 mM phenylmethylsulfonylﬂuoride,
2 mg/mL aprotinin) and homogenized on ice using an
Ultra-Turrax homogenizer (IKA, Staufen, Germany) at
medium speed. The homogenate was centrifuged at
14,000  15 min at 4C. Protein concentrations were
estimated using Bradford assay (Sigma-Aldrich, St.
Louis, MO, USA) using bovine serum albumin as the
standard.
Subsequently 50 mg of total protein extracts were
heated to 95C for 5 min and electrophoresed on
10% polyacrylamide gel (sodium dodecyl sulphate-
polyacrylamide electrophoresis [SDS-PAGE]) under
reducing conditions. Proteins were electrophoretically
transferred to nitrocellulose membrane (Bio-Rad, Mel-
ville, NY, USA); complete transfer was assessed using
prestained protein standards (Bio-Rad). Blots were
placed in PBS, pH 7, containing 5% non-fat dried milk
and 0.1% Tween-20 (blocking solution) and incubated
for 60 min at 37C. After washing in PBS containing
0.1% Tween-20, blots were incubated with p120ctn
monoclonal antibody (Transduction Laboratories)
1:1000 in blocking solution for 60 min at RT. The
membranes were then washed ﬁve times with PBS
containing 0.1% Tween-20 before incubation with
secondary antibody, horseradish peroxidase-conjugated
goat anti-mouse IgG (Santa Cruz Biotechnology Inc.)1:10000 in blocking solution for 60 min at RT. Blots
were ﬁnally washed ﬁve times in PBS containing 0.1%
Tween-20, processed with Super Signal West Pico
Chemiluminescent substrate (Pierce, Rockford, IL,
USA) and autoradiographed. To conﬁrm equal protein
loading per lane, membranes were subsequently reacted
with 1:5000 dilution of a mouse monoclonal antibody
to b-actin (Sigma-Aldrich).
The relative signal intensity of CRADD (CASP2 and
RIPK1 domain containing adaptor with death domain)
and APAF-1 (apoptotic protease activating factor-1)
protein detected in blots of tissue samples was quanti-
ﬁed using Quantity One 1-D Analysis software
(Bio-Rad Laboratories).Immunohistochemistry
Four micrometer serial sections from routinely formalin
ﬁxed parafﬁn embedded blocks were cut for each case
and mounted on poly-L-lysine coated glass slides.
Standard deparafﬁnization and rehydratation of slides
were performed. One section stained with H&E was
used to conﬁrm the histopatological diagnosis. Only
sections showing sufﬁcient epithelium to assess 1000
cells were considered for this study. Immunohisto-
chemistry was then performed on the sections mounted
on poly-L-lysine coated glass slides using labeled
Streptavidin-biotin-alkaline phosphatase technique
(LSAB-AP). To improve the staining pattern, the
sections were boiled 3 times for 3 min in 10 mM citrate
buffer as antigen retrieval method. In order to prevent
non-speciﬁc binding sections were then preincubated
with non-immune bovine serum (diluted 1:100 in PBS)
for 25 min at RT. After 3 washes in TriseHCl buffer,
the slides were incubated overnight with the primary
mouse monoclonal antibody against p120ctn (Trans-
duction Laboratories) diluted 1:300 using 0.05 M
TriseHCl buffer pH 7.2-7.6, containing 1% bovine
serum albumin. A negative control was performed
in each run by substituting primary antibodies with
non-immune reagent (Dako Antibody Diluent). Pos-
itive controls were performed in each run, using
sections of normal skin/oral mucosa biopsies. Sequen-
tial 20-min incubations with biotinylated anti-mouse
immunoglobulins and streptavidin conjugated to alka-
line phosphatase were performed. Finally, fuchsine
substrate system (K6998, Dako) was applied as a chro-
mogenic solution. The slides were then counterstained
with hematoxylin.Statistical analysis
Data were compiled and analyzed in both a quantitative
and semi-quantitative manner. The number of p120ctn
expressing tumor cells was estimated as a percentage of
the ﬁnal number of 500 neoplastic cells of each case.
Fig. 1. (A) p120ctn localization in NCTC cell line by immunoﬂuorescence: diffuse cytoplasmic staining and small well deﬁned
nuclear areas (400); (B) Intracellular distribution of p120ctn in KM5 cell line: the staining was mostly diffuse, but was also
associated with small punctate membranous structures at cellecell contact and discrete dots in the nuclear region. (1000, Nuclei
were counterstained with Propidium Iodide); (C) Expression of p120ctn in OSC20 cell line (LSAB-AP, 400); (D) Nuclear
expression of p120ctn in KM5 cell line (LSAB-AP, 400).
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identiﬁed including percentage and cellular localization
of p120ctn: 0 (less than 10% of positive cells); 1
(>90% of normal membranous staining); 2 (>50% of
cells with delocalized cytoplasmic staining or >3%
nuclear staining). For the quantitative analysis, the
percentage of p120ctn expression was evaluated in
continuous scale of values ranging from 0 to 100%.
Differences between groups were analyzed with the
StudenteNewmaneKeuls test. Correlation by Pear-
son’s method was also calculated to establish connec-
tion and to quantify the strength of the association
between variables. Survival curves were analyzed
according to the method of KaplaneMeier and for
differences between curves, the P value was calculated
by the log-rank test. A P value of less than .05 was
accepted as statistically signiﬁcant.
RESULTS
p120ctn expression in oral cell lines
NCTC2544 showed a prevalent membranous positi-
vity, even if polarized to cellecell adhesion sites
(Figure 1A). All neoplastic cell lines showed a prev-
alent cytoplasmic localization or no staining. CAL33
cells showed a membranous positivity in only 30% of
cells, cytoplasmic positivity in 35% or no positivity in
35%. CAL27 showed a membranous positivity in
only 20% of cells, cytoplasmic positivity in 40% or
no positivity in 40%. OSC20 cells showed
a membranous positivity in 40% of cells, cytoplasmic
positivity in 20% or no positivity in 40%. KM5 cellsshowed a membranous positivity in only 10% of
cells, cytoplasmic positivity in 40% or no positivity in
40%; in 10% of the cells there was a nuclear locali-
zation (Figure 1B, C, and D). Descriptive statistics for
percentage of p120ctn expression in OSCC cell lines
demonstrated a level of positivity ranging from 60%
(CAL27, OSC20, KM5) to 65% (CAL33), showing
no statistically signiﬁcant difference between cyto-
logical degree of differentiation when compared with
one-way analysis of variance (ANOVA) and Stu-
denteNewmaneKeuls tests. However, in cancer cells,
p120ctn showed an inverse relationship with the
degree of differentiation for a progressive displace-
ment of the signal toward the cytoplasm or nucleus in
dedifferentiated cells, even though it was not statis-
tically signiﬁcant.
To conﬁrm and better evaluate intracellular distri-
bution of p120ctn, we probed the above cell lines by
immunoﬂuorescence. All cell lines showed diffuse
staining for p120ctn. The protein localized both to
cellecell contacts, especially in NCTC2544 and
OSC20, and in the cytoplasm. Furthermore, in all cell
lines, several cells showed a nuclear localization, which
was conﬁrmed by DNA counterstaining with propidium
iodide. In the nuclear region, p120ctn-related green
ﬂuorescence was appreciable as small, well-deﬁned
areas (Figure 1A and B).
Expression levels of p120ctn in oral cell lines were
assayed by WB (Figure 2A). Anti-p120 Mab recognized
bands ranging from 90 to 115 kDa and the protein was
detectable in all cell lines. A reduced expression
Fig. 2. WB showing expression levels of p120ctn
(w120 KDa) and b-actin (40 KDa) in protein extracts from cell
lines (A) and tissue samples (B). p120ctnwaswell expressed by
all cell lines with the exception of KM5. There was a poor
correlation between differentiation degree and expression
pattern (A). Oral cancer expressed different levels of p120ctn
with respect to normal mucosa. Poorly differentiated carci-
nomas (5, 6, 10) corresponded to a reduced expression of
p120ctn. Well-differentiated carcinoma (2) showed no reduc-
tion in expression of protein compared to normal mucosa (1).
Expression of b-actin was consistent among all samples (B).
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and CAL27, showed overexpression of the protein
with respect to NCTC2544, a well-differentiated
immortalized keratinocyte cell line. The intensity of
b-actin protein was almost equal in all cell samples.
These results suggested a poor correlation between
p120ctn expression pattern and the degree of cellular
differentiation, but examined expression levels only,
without any distinction as to intracellular localization of
the protein.
p120ctn expression in normal mucosa and OSCC
All 12 normal oral specimens showed homogenous
membranous p120ctn localization (Figure 3A and B).
Membranous staining was observed at the intercellular
borders of histologically normal oral epithelium present
in the OSCC specimens, although no staining was seen
in the most superﬁcial cells.
Abnormal staining patterns (negative, cytoplasmic,
or nuclear) of p120ctn were seen in 96% (109/113) of
cases. Complete loss of expression was found in 15%
(21/113) of OSCC.Well-differentiated OSCC (G1) showed a distri-
bution pattern for p120 quite similar to that observed
in normal epithelium. In fact, a high percentage of
tumor cells showed a membranous staining pattern
(Figure 3C). However, in several cases, predominantly
G2, a lack of membrane localization for p120ctn was
observed, since the signal was cytosolic (Figure 3D and
E). Absence of membrane localization and cytosolic or
nuclear staining for p120ctn were detected in poorly
differentiated OSCC (G3) (Figure 3F).
Expression of p120ctn in tissue extracts of normal
mucosa and OSCC was also demonstrated by WB
(Figure 2B). p120ctn was detectable in all normal
mucosa and OSCC but at different levels. Well-
differentiated carcinomas showed similarly increased
protein expression compared with normal mucosa,
while the reduced expression was notable, as was the
occasional lack of immunoreactive bands of p120ctn in
poorly differentiated carcinomas.Statistical analysis
There was a statistically signiﬁcant difference (P < .05)
in delocalization of p120ctn in OSCC’s when compared
with the control group. However p120ctn expression did
not show statistically signiﬁcant differences when
compared with clinicopathological indices (Table I).
Survival curves, comparing no expression of p120ctn
(score 0) and normally membranous expression (score 1)
and delocalized expression (score 2) by KaplaneMeier
method, showed statistically signiﬁcant differences
(P < .05) (Figure 4).DISCUSSION
The p120ctn protein is a member of the catenin
family.7,29,30 It has been demonstrated that p120ctn
binds to the same region of E-cadherin as the rest of the
catenins, acting as a regulatory protein of the adhesive
function of E-cadherin.7,30 The interaction with juxta-
membrane domain of cadherins allows p120ctn to
affect cell adhesion, and has identiﬁed additional roles
in the nucleus.31 p120ctn goes into the nucleus,32 but
unlike b- and g-catenin, it interacts with the transcrip-
tion factor Kaiso, considered a possible transcription
factor for p120ctn,33 and a candidate downstream
effector of cadherin and/or p120ctn signaling.34
Several studies have demonstrated that loss or
reduction of p120ctn expression is frequently associ-
ated with high grade and advanced stage in a variety of
malignancies,20,35-37 including squamous cell carci-
noma of the skin19 and recently also OSCC.22
To best evaluate the correlation between p120ctn
expression levels and cellular differentiation, cell lines
were chosen taking the differentiation degree into
account. All lines demonstrated immunoreactivity for
Fig. 3. (A) Normal pattern of staining for p120ctn in oral epithelium, with a deﬁnite cytoplasmic membrane localization (LSAB-
AP, 150); (B) Normal pattern of staining for p120 in oral epithelium; higher magniﬁcation (LSAB-AP, 400); (C) Membranous
staining for p120ctn in a case of G1/G2 OSCC, predominantly at the invasive front of the tumor (LSAB-AP, 150); (D) Loss of the
membrane staining for p120ctn in a case of G2 OSCC with a poor prognosis (LSAB-AP, 250); (E) Cytoplasmic delocalization of
immunopositivity for p120ctn in a case of G2 OSCC (LSAB-AP, 106); (F) A case of G2/G3 OSCC: some cells showed a loss of
the membrane staining for p120ctn with nuclear delocalization of the signal, while other cells showed a ring of cytoplasmic
membrane and nuclear membrane positivity (LSAB-AP, 400).
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agreement with the differentiation degree. In addition
to total protein amount, it is likely that catenin locali-
zation must also be considered. NCTC2544 showed
a membranous expression of the protein, especially at
the site of cellecell adhesion. Immunoﬂuorescence
conﬁrmed a preferential localization to cellecell
contact and showed slight cytoplasmic staining.
Abnormal staining patterns (either negative, heteroge-
nous or cytoplasmic) of p120ctn were seen in OSCC
cell lines (CAL27, CAL33, OSC20). High cytoplasmic
expression of p120ctn is probably due to an increase of
the free p120ctn fraction in tumor cells, similar to that
of b-catenin.38 A small number of neoplastic cells
(CAL27, CAL33, OSC20, KM5) showed no positivity,
while 30%-35% showed a reduction of expression.
Absent or reduced catenin immunostaining in poorly
differentiated tumor cells can be explained by a loss of
their functions and structures. In fact the maintenance
of tissue architecture depends on the function of cad-
herins,39 which relies on interactions with catenins.A total of 10% of KM5 cells, characterized by poorly
differentiated keratinocytes, showed a nuclear positivity
by immunocytochemistry. Immunoﬂuorescence revealed
a small fraction of cells showing a nuclear signal in
all cell lines. Thus, p120ctn nuclear localization could
suggest a potential involvement of this protein in sig-
naling and eventually in cancer transformation, even if
its role is still unknown.
These data were conﬁrmed by the immunohisto-
chemical evaluation. Abnormal staining patterns
(negative, heterogenous, cytoplasmic, or nuclear) of
p120ctn were seen in 96% (109/113) of cases.
Complete loss of expression was found in 15% (21/
113) of OSCC while normal oral epithelium showed
membranous expression of p120ctn at the cellecell
borders, reﬂecting the normal localization of intercel-
lular adhesion molecules, similar to that of
b- and g-catenins.14,15,40
All the cases in this study showed strong reactivity
with p120ctn in areas of normal epithelium (Figure 3A
and B). A similar pattern of staining was observed in all
Table I. Statistical analysis of p120ctn score expression and associated clinicopathological ﬁndings in oral SCCs
Variables No.
Score
0 n.
Score
1 n.
Score
2 n. Mean
Standard
deviation
Standard
error
P
< .05 Statistical data
Cases 113 21 4 88
Age
65 years 59 10 3 46 1.610 0.7660 0.09973 No* P ¼ .9339
>65 years 54 11 1 42 1.574 0.8150 0.1109
Sex
Male 77 12 4 61 1.500 0.8783 0.1464 No* P ¼ .3747
Female 36 9 0 27 1.636 0.7418 0.08453
Grading Mean difference q P value
G1 39 8 0 31 1.590 0.8181 0.1310 No G2 vs. G3 0.03414 0.2360 >.05
G2 53 9 4 40 1.585 0.7705 0.1058 G2 vs. G1 0.00483 e >.05
G3 21 4 0 17 1.619 0.8047 0.1756 G1 vs. G3 0.02930 e >.05
Size
<1.5 cm 50 9 1 40 1.620 0.7796 0.1103 No* P ¼ .7460
>1.5 cm 63 12 3 48 1.571 0.7975 0.1005
Lymph node
metastasis
Negative 87 15 2 70 1.632 0.7642 0.08194 No* P ¼ .3339
Positive 26 6 2 18 1.462 0.8593 0.1685
Staging Mean difference P value
I 53 9 1 43 1.642 0.7619 0.1047 Stage III vs. stage IV 0.2724 >.05
II 24 5 1 18 1.542 0.8330 0.1700 Noy Stage III vs. stage I 0.2297 >.05
III 17 4 2 11 1.412 0.8703 0.2111 Stage III vs. stage II 0.1299 >.05
IV 19 3 0 16 1.684 0.7493 0.1719 Stage II vs. stage IV 0.1425 >.05
Stage II vs. stage I 0.0998 >.05
Stage I vs. stage IV 0.0427 >.05
Recidive
Yes 40 7 1 32 1.525 0.8469 0.1339 No* P ¼ .4992
No 73 14 3 56 1.630 0.7547 0.08834
*StudenteNewmaneKeuls’ test.
yOne-way analysis of variance (ANOVA) and StudenteNewmaneKeuls multiple comparisons test.
Fig. 4. Survival curves, comparing low/no expression of
p120ctn (score 0), normal membranous expression (score 1)
and delocalized expression (score 2) by KaplaneMeier
method, show statistically signiﬁcant differences (P < .05).
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contrast, the inﬁltrating areas of moderately differenti-
ated tumors showed a lower or absent signal, with
a general reduction of staining intensity at the periph-
eral border of cancer nests. Poorly differentiated OSCC
showed a homogenous decrease and/or a total lack ofimmunostaining, even if some cases showed nuclear
positivity (Figure 3C-F). The reduction of expression
and the altered localization of p120ctn are very
common events during the development and/or
progression of SCCs.19
The similarity in staining pattern between normal
squamous epithelium and well-differentiated OSCC of
our series supports the existence of a possible rela-
tionship between p120ctn expression and the degree of
cellular differentiation. This is further supported by the
ﬁnding of low or absent membranous immunopositivity
both in poorly differentiated OSCC and at the invasive
front of moderately OSCC. This data was conﬁrmed by
WB which evidenced a reduction of p120ctn expression
in poorly differentiated OSCC with loss of immunore-
active bands in some samples, while well differentiated
OSCC showed the same pattern, or in some instances,
a overexpression of the protein with respect to normal
mucosa.
Analysis of p120ctn expression in OSCC might be
useful in identifying tumor areas with more aggressive
potential in well and moderately differentiated tumors,
in addition to the study of E-cadherin expression and
other conventional markers such as those related to
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able, such as the pattern of invasion, which did not
show any correlation with the degree or with the
topography of the immunopositivity.
Up-regulation of p120ctn cytoplasmic staining,
already described for other tumors,41 was also seen in
OSCC. High cytoplasmic expression of p120ctn is
probably due to an increase of the free p120ctn fraction
in tumor cells, and could suppose a potential involve-
ment in cancer transformation.42 Furthermore, altered
localization of this protein is prognostic for aggressive
disease in some tumors, like breast or colon carci-
noma.17,20 The exact role of p120ctn is not yet
completely clear, but this molecule seems to have an
unexpected dual function, promoting tumor suppression
or inducing neoplastic transformation, depending on
whether E-cadherin is present or not.43
The E-cadherin-catenin complex is the mediator of
intercellular cohesion and epithelial tissue integrity.
Epithelial-mesenchymal transition (EMT) is the process
by which epithelial cells adopt a mesenchymal pheno-
type or ﬁbroblast-like properties, reorganizing their
cytoskeleton and breaking connections with their
neighbors, and is suggested to play an important role
during cancer invasion and metastasis. The best-studied
process of EMT is “cadherin switching,” involving the
inhibition of E-cadherin expression, and an aberrantly
high expression of N-cadherin.44 The disturbance in E-
cadherin-p120ctn leads to accumulation in the cyto-
plasm of this protein, conﬁrmed by the abnormal
staining pattern. It has been demonstrate that p120ctn
can down-regulate the enzymatic activity of GTPase
enzymes that regulates actin assembly, causing insta-
bility of intercellular adhesion and inducing cell
migration through the formation of lamellipodia and
ﬁlopodia.45 These ﬁndings lead to candidate p120ctn as
another protein for the control of the metastatic poten-
tial of tumors, as down-regulation of adhesion is
a primary event in metastasis.46,47 However, p120ctn
shows heterogenous expression pattern, with isoform
variability, but no evidence of complete loss of
expression in tumor cell lines, such as other adhesion
proteins.48
Abnormal staining pattern of p120ctn can reﬂect
reduction or loss of adhesion, as in other human
malignancies. The strong correlation seen in OSCC
between loss of membranous immunoreactivity and
grade suggests that alterations in E-cadherin-p120ctn
complex expression and function play an important role
in OSCC tumor progression. Several reports have
shown that loss of membranous E-cadherin expression
in OSCC is associated with advanced stage and
progression.
To date, no studies have found a correlation between
p120ctn expression in OSCC and patient survival. Inthis study. Data showed an inverse association between
the percentage of stained cells and the survival rate.
Indeed, the results indicated that patients with loss of
p120ctn expression had poorer survival rates than the
group with normal p120ctn expression (P < .05).
Moreover, cases presenting p120ctn cellular delocal-
ization showed a worse survival rates than the group
with normal p120ctn expression. When p120ctn and
others clinicopathological features, such as grading and
staging, were analyzed for prognostic signiﬁcance, no
statistically signiﬁcant correlations were detected. Thus,
the level of p120ctn expression could be considered as
an independent prognostic factor. This ﬁnding was
conﬁrmed by a very recent work that displayed how in
potentially malignant oral lesions the mislocalisation of
expression of p120ctn from the cell membrane to the
cytoplasm is associated with oral cancer progression.22
Stairs et al. reported that in a conditional knockout
model of p120ctn in mice, the tumor-derived cells
secrete granulocyte macrophage colony stimulating
factor (GM-CSF), macrophage colony stimulating fac-
tor (M-CSF), monocyte chemotactic protein-1 (MCP-1)
and tumor necrosis factor-a (TNF-a). These cyto-
kines create a favorable tumor microenvironment with
inﬂammatory and tumorigenic features, and with a
signiﬁcant percentage of immature myeloid cells, that
have the ability to suppress antigen-speciﬁc T cell
activation. These results suggest that p120ctn can be
considered “de facto” a tumor suppressor gene.49
In conclusion, we have shown that loss of physiolog-
ical membranous p120ctn immunoreactivity occurs in
96% of OSCCs, and, as already reported for E-cadherin,
b- and g-catenin, the reduction or the absence of
p120ctn expression was correlated to poor prognosis.
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